Blood biomarker that predicts persistent cognitive dysfunction after concussion
US11761959B2 · kind B2 · utility
2Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Sep 19, 2023 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to methods for providing prognosis, diagnosis, and treatment of a mild traumatic brain injury (mTBI) in a computed tomography (CT)-negative subject. The invention further relates to monitoring the severity of brain damage resulting from TBI in a subject and determining the prognosis of a subject that has suffered from mTBI. This invention also relates to methods of predicting who is at risk for developing brain damage and long-term dysfunction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.